Dose-Efficacy of rTMS in Healthy Young Female Volunteers

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 11, 2024

Primary Completion Date

April 1, 2025

Study Completion Date

June 1, 2025

Conditions
Fecal Incontinence (FI)Healthy Female Volunteer
Interventions
DEVICE

rTMS and rTLSMS administered using a Magstim Rapid2 repetitive stimulator at pre-identified hotspots (cortical, lumbar, and sacral regions bilaterally).

rTMS and rTLSMS administered using a Magstim Rapid2 repetitive stimulator at pre-identified hotspots (cortical, lumbar, and sacral regions bilaterally. rTMS delivered with 250 pulses via the same double-cone coil used for the neurophysiological study, at either 1 Hz or 5 Hz. For rTLSMS (lumbar and sacral), 2400 pulses (600 per hotspot) were applied at 1 Hz, 5 Hz, or 10 Hz using a 70mm refrigerated air film coil (Magstim, UK). Each dose and stimulation site (cortical or peripheral) were tested in separate sessions.

Trial Locations (1)

08304

Hospital de Mataró, Mataró

All Listed Sponsors
lead

Hospital de Mataró

OTHER

NCT07192328 - Dose-Efficacy of rTMS in Healthy Young Female Volunteers | Biotech Hunter | Biotech Hunter